WebBICC1-FGFR2 Fusion is present in 0.02% of AACR GENIE cases, with intrahepatic cholangiocarcinoma, adenocarcinoma of unknown primary, cancer of unknown primary, … WebIn the present work, we present a case of cholangiocarcinoma who had FGFR2-BICC1 rearrangement detected by NGS. A 76-year-old female diagnosed with cholangiocarcinoma underwent four cycles of chemotherapy. The NGS assay showed that the tumor had a FGFR2-BICC1 rearrangement. The patient had a favorable tumor response to sorafenib.
FGFR2-BICC1 : A Subtype Of FGFR2 Oncogenic Fusion Variant In ...
WebMay 27, 2024 · The FDA has approved Balversa (erdafitinib) as a treatment for adult patients with locally advanced or metastatic bladder cancer that have FGFR3 or FGFR2 abnormalities and that has progressed during or following … WebFGFR2-BICC1 Fusion is present in 0.10% of AACR GENIE cases, with intrahepatic cholangiocarcinoma, adenocarcinoma of unknown primary, cholangiocarcinoma, … dahl fuel filters diesel
Remarkable Response to Erdafitinib in Metastatic Lung Adenocarcinoma ...
WebExplore: Forestparkgolfcourse is a website that writes about many topics of interest to you, a blog that shares knowledge and insights useful to everyone in many fields. WebApr 21, 2024 · BICC1 was found to be the most common partner gene of FGFR2. CHOL, UCEC, and SKCM are the three cancer types that harbor the highest frequencies of FGFR2 alteration. In CHOL, fusion accounted for the major proportion, while in UCEC and SKCM, mutation was the dominant alteration. Web1 day ago · [35], [36] In addition, three different FGFR2 fusion proteins FGFR2/TACC3, FGFR2/MGEA5 and FGFR2/BICC1 that were isolated from intrahepatic cholangiocarcinoma (ICC) samples and the FGFR3 translocation protein in bladder cancer are all reported to be Hsp90 clients. These proteins undergo rapid degradation through ubiquitin conjugation in … dahl funeral bozeman obituaries